CLL-1265: Pirtobrutinib, Venetoclax, and Obinutuzumab Treatment in First-Line CLL (PIVOT-CLL)
Nitin Jain, Alessandra Ferrajoli, Mahesh Swaminathan, Jan Burger et autres
0 citationsClinical Lymphoma Myeloma & Leukemia
Guillermo Garcia-Manero
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
24Publications signalées
0Citations signalées
1Affiliations récentes
Institutions déclarées
Domaines associés
Acute Myeloid Leukemia ResearchChronic Myeloid Leukemia TreatmentsMyeloproliferative Neoplasms: Diagnosis and TreatmentChronic Lymphocytic Leukemia ResearchLymphoma Diagnosis and Treatment
Publications récentes
POSTER: ALL-866: Three-Year Follow-Up of Dose-Dense Mini-CVD in Combination With Inotuzumab Ozogamicin and Blinatumomab for Patients With Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia
Hannah Goulart, Hagop M Kantarjian, Nitin Jain, Farhad Ravandi et autres
0 citationsClinical Lymphoma Myeloma & Leukemia
AML-460: Long-Term Follow-Up of Oral Decitabine/Cedazuridine (ASTX727) Plus Venetoclax in Older or Unfit Patients With Newly Diagnosed Acute Myeloid Leukemia
Thura Win Htut, Jeannot Kekedjian, Nicholas Short, Alexandre Bazinet et autres
0 citationsClinical Lymphoma Myeloma & Leukemia
AML-520: Myelodysplasia-Related Mutation Clearance Is Associated With Improved Outcomes in Newly Diagnosed Acute Myeloid Leukemia Treated With Low-Intensity Therapy
Naszrin Arani, Sanam Loghavi, Courtney DiNardo, Gautam Borthakur et autres
0 citationsClinical Lymphoma Myeloma & Leukemia
AML-1177: Revumenib as Maintenance for AML Following Allogeneic Stem Cell Transplantation
Hannah Goulart, Olayinka Okeleji, Courtney DiNardo, Naval Daver et autres
0 citationsClinical Lymphoma Myeloma & Leukemia
POSTER: CLL-1265: Pirtobrutinib, Venetoclax, and Obinutuzumab Treatment in First-Line CLL (PIVOT-CLL)
Nitin Jain, Alessandra Ferrajoli, Mahesh Swaminathan, Jan Burger et autres
0 citationsClinical Lymphoma Myeloma & Leukemia
POSTER: AML-1177: Revumenib as Maintenance for AML Following Allogeneic Stem Cell Transplantation
Hannah Goulart, Olayinka Okeleji, Courtney DiNardo, Naval Daver et autres
0 citationsClinical Lymphoma Myeloma & Leukemia
MDS-113: Updated Overall Survival and Long-Term Transfusion Independence From the Phase 3 COMMANDS Trial in Erythropoiesis-Stimulating Agent–Naïve Patients With Lower-Risk Myelodysplastic Syndromes
Guillermo Garcia-Manero, Matteo Giovanni Della Porta, Amer M Zeidan, Rami S. Komrokji et autres
0 citationsClinical Lymphoma Myeloma & Leukemia
ALL-866: Three-Year Follow-Up of Dose-Dense Mini-CVD in Combination With Inotuzumab Ozogamicin and Blinatumomab for Patients With Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia
Hannah Goulart, Hagop M Kantarjian, Nitin Jain, Farhad Ravandi et autres
0 citationsClinical Lymphoma Myeloma & Leukemia
POSTER: AML-872: Characteristics and Clinical Outcomes of DDX41-Mutated Myeloid Neoplasms Treated With Lenalidomide: Single-Center Retrospective Study
Jacob Herstein, Jennifer Marvin‐Peek, Sanam Loghavi, Koichi Takahashi et autres
0 citationsClinical Lymphoma Myeloma & Leukemia
AML-1545: Quizartinib Combined With Cladribine, Idarubicin, and Cytarabine in AML
Musa Yilmaz, Tapan Kadia, Courtney DiNardo, Nicholas Short et autres
0 citationsClinical Lymphoma Myeloma & Leukemia
ORAL ABSTRACT: CLL-1265: Pirtobrutinib, Venetoclax, and Obinutuzumab Treatment in First-Line CLL (PIVOT-CLL)
Nitin Jain, Alessandra Ferrajoli, Mahesh Swaminathan, Jan Burger et autres
0 citationsClinical Lymphoma Myeloma & Leukemia
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.